health_en

Alamar Biosciences partners with Abcam to drive understanding of the human proteome

Alamar selects Abcam as a key provider of antibody content for its propriety NULISA technology platform Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences research tools, today announced a strategic partnership […]

thaipr.net

4 ม.ค. 65

Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world’s largest vaccine manufacturer by volume, today announced that the Drugs Controller General of India (DCGI) has granted emergency use authorization (EUA) for Novavax’ recombinant nanoparticle protein-based COVID-19 vaccine…

thaipr.net

29 ธ.ค. 64

2020 Global Survey from ISAPS Sees Significant Changes in Aesthetic Procedures During Pandemic

COVID-19 practice closures lead to a 10.9% decrease in surgical procedures The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures today, which showcased the impact of the COVID-19 pandemic on aesthetic plastic surgery procedures worldwide throughout 2020. Highlights  Plastic surgery procedures for aesthetic purposes decreased […]

thaipr.net

29 ธ.ค. 64

Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies

– Two-dose primary regimen of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron (B.1.1.529) and other variants – Third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials, with a 9.3-fold IgG rise and a 19.9-fold ACE2 inhibition increase after booster dose – Immune responses in adolescents were 2- to […]

thaipr.net

23 ธ.ค. 64

LINEPHARMA INTERNATIONAL FILES FOR MANUFACTURING, MARKETING APPROVAL OF THE ABORTION PILL IN JAPAN

Linepharma International Ltd., a global leader in medical abortion, announced today that its subsidiary Linepharma KK has applied for manufacturing and marketing approval in Japan for its oral drug MEFEEGO™ for the medical termination of pregnancies of up to 63 days of gestation. The medication is recognized as the international gold standard for first trimester medical […]

thaipr.net

23 ธ.ค. 64

Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories

– Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications in Europe (including the United Kingdom), Latin America and Other Key Countries – Karyopharm to Receive $75 Million Upfront, then Eligible to Receive Up to $202.5 Million in Future Milestones, Plus Tiered, Double-digit Royalties on Net […]

thaipr.net

23 ธ.ค. 64

Technology central to sustainability, affordability of global healthcare industry

Artificial Intelligence & Machine learning drive better health outcomes and affordability Healthcare spending saw a steep decline during the COVID-19 pandemic with associated lockdowns, restrictions, and postponement of non-essential treatments. However, the trend is expected to be short-lived as COVID-19 vaccines and testing became widely available, and healthcare usage begins to rebound. “Almost every year, and with […]

thaipr.net

22 ธ.ค. 64
1 … 84 85 86 87 88 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.